New Head of Medico-Marketing Offers and Business Development

🔔 Enosium Life Science Welcomes Gabriel MARTIN as Head of Medico-Marketing Offers and BD🔔

‍

We are thrilled to announce that Gabriel Martin has joined our team as the Head of Medico-Marketing and Business Development activities. 🎉

With over 20 years of experience in the pharmaceutical and biotechnology markets, Gabriel brings unique expertise and a deep passion for science and innovation, values that are at the core of our mission at Enosium Life Science.

‍

🚀 An Impressive Journey

‍

Gabriel’s academic background includes a Master's in Marketing and a Postgraduate degree in Immunology, which laid the foundation for an impressive career focused on bringing scientific innovations to market and making them accessible to patients and healthcare professionals.

Before joining Enosium Life Science, Gabriel has led the French and Belgian businesses of ViiV Healthcare and Vertex Pharmaceuticals. During these years, he successfully launched innovative medicines that significantly impacted the lives of patients with severe conditions such as cystic fibrosis and HIV. His passion for the healthcare industry, his collaborative approach with stakeholders, and his inspiring leadership align perfectly with our values.

‍

🤝 A Promising Future

‍

Gabriel’s arrival marks a key milestone in our development, and we are confident in the value he will bring to our organization. He will oversee the group’s Medico-Marketing consulting activities, including Medical Education, Scientific Communication, and Marketing for our pharma, biotech, and medtech clients. Additionally, in close collaboration with our CEO and founder, Antoine Amer, Gabriel will coordinate the identification, evaluation, and engagement with our future partner companies.

At Enosium Life Science, we are committed to addressing the challenges of our ecosystem to enable broader and faster access for European patients to medical innovations.

‍